Pharmaceutical Composition Comprising NANOG SHRNA, and Method of Using NANOG SHRNA to Treat Cancer
Technology
E-294-2010
Patent ID
E-294-2010-0-US-03
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
9163236
Publication Number
US20140303230A1
Application Number
13/991,989
IC
NCI
Date Filed
Date Issued